EFTA Document EFTA01842139

To: Jeffrey epsteinijeevacationagmallcomj From: Lesley Groff Sent Thur 2/9/2012 2:23:27 PM Subject Re: Hi Jeffrey I will add to your schedule you arc to meet with Ted Kaptchu at 1 Brattle Square at Harvard on April 12th at 5pm! On Feb 9, 2012, at 8:10 AM, jeffrey epstein wrote: 5? Sony for all the typos .Scut from my iPhone On Feb 9, 2012, at 8:31 AM, can set set an approximate time? wrote: Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email: Web: www.proeraminplacebostudies.orq On Feb 7, 2012, at 2:27 PM, Jeffrey Epstein wrote: ped martin novak On The, Feb 7, 2012 at 3:25 PM, . IIIMEIM> wrote: what time? any office at I Bratt lc Sq. ted Ted J. Kaptchuk EFTA_R1_00228897 EFTA01842139 Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Bost Phone Email: Web: www.programinplacebostudies.orq On Feb 7, 2012, at 2:22 PM, Jeffrey Epstein wrote: I brattle square On Tuc, Feb 7, 2012 at 3:12 PM, wrote: Jeffrey, I think it may be a good idea to set up a time to meet on April 12 in Cambridge. As a location, I can offer my home office ncar Harvard Sq, my office at the medical school, or any tea shop in the area. Or do you have another preference? Suggest a time as i'm flexible that day. ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston MA Phone: Email: Web: www.proc • EFTA_R1_00228898 EFTA01842140 On Feb 6, 2012, at 5:53 PM, Jeffrey Epstein wrote: cambridge april 12, but phone availble before On Mon, Feb 6, 2012 at 5:15 PM, • wrote: Hi Jeffrey, When is a good time to talk about placebo? When are you next in Cambridge? ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email: Web: www.procraminplacebostudies.orq On Jan 13, 2012, at 3:15 PM, Jeffrey Epstein wrote: EFTA_R1_00228899 EFTA01842141 Im in africa until the 27th On Fri, Jan 13, 2012 at 9:05 PM, wrote: Hi Jeff, I'm around Monday, Martin Luther King day until 3pm. Is that a good day for a phone conversation? Alternatively, as the phone hasn't been too successful, should we meet in person? When arc you in Cambridge next? ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston MA 02215 Phone: Email: Web: www.programinplacebostudies.orq EFTA_R1_00228900 EFTA01842142 On Dec 25, 2011, at 1:31 PM, Jeffrey Epstein wrote: lets alk on tue On Sun, Dec 25, 2011 at 2:04 PM, ote Is th Cr a go od ti to ch Cc 1:- EFTA_R1_00228901 EFTA01842143 in wi th yo to ge t yo ur fe ed ba ck on th bu dg et w se nt yo tw 0 w cc ks ag 0 an d on w ha t iss uc w ou Id int EFTA_R1_00228902 EFTA01842144 er est yo in de ye lo Pi ng a pa rtn er shi p wi th ou r eff or is in pl ac cb 0 st ud ies 9 w e'r in g to thi nk bo t sci en tifi EFTA_R1_00228903 EFTA01842145 cal ly an d str at eg ica Ily 0 ur to a ha all th int ell cc tu al an d inf ra str uc tu re re so ur ce of H ar va rd U ni ve EFTA_R1_00228904 EFTA01842146 Best, ted rsi tY an d an in pu t w ou Id be ap pr eci at cd T ed J. K ap tc hu k ss oc !at e Pr of es so EFTA_R1_00228905 EFTA01842147 of M ed ici ne Harvard Medical School Director, Program in Placebo Studies & T he ra pe uti E nc ou nt er Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email. Web: www.programinolacebostudies.orq On Dec 5, 2011, at 2:41 PM, Jeffrey Epstein wrote: now? n M wrote: I tried calling you on November 28. No answer. Our work is getting enormous media attention. (Attached is an article in this week's New Yorker. I wished it had focused more on our science and less on me. We expect coverage by "60 Minutes" in January.) EFTA_R1_00228906 EFTA01842148 This is a critical time to develop our scientific and institutional roots at Harvard. We're looking for partners to help move our research along. Would there be another time you could talk by telephone? Best ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email: Web: www.programinplacebostudics.org ************************************* The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this EFTA_R1_00228907 EFTA01842149 communication or any pan thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacationOgmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly pro hibi tcd and may be unlawful. If you have received this communication in error, please notify us im me diat cly by return e-mail or by e-mail to EFTA_R1_00228908 EFTA01842150 sn @la 1.0 and destroy this communication and all copies thereof, including all attachments. copyright -all rights ICS cry ed ************ The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any pan thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this EFTA_R1_00228909 EFTA01842151 communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved ** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved *********************************************************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00228910 EFTA01842152